Pulse Biosciences Inc (NASDAQ:PLSE) major shareholder Robert W. Duggan bought 205,127 shares of Pulse Biosciences stock in a transaction dated Saturday, March 18th. The stock was acquired at an average price of $23.56 per share, for a total transaction of $4,832,792.12. Following the completion of the acquisition, the insider now owns 2,174,479 shares in the company, valued at $51,230,725.24. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Large shareholders that own 10% or more of a company’s shares are required to disclose their transactions with the SEC.

Pulse Biosciences Inc (NASDAQ:PLSE) traded down 5.96% during mid-day trading on Monday, hitting $23.03. 426,087 shares of the stock were exchanged. Pulse Biosciences Inc has a 52-week low of $4.03 and a 52-week high of $25.15. The stock’s 50 day moving average is $13.18 and its 200 day moving average is $7.81. The stock’s market cap is $306.62 million.

Your IP Address:

This article was originally published by and is the sole property of American Banking News. If you happen to be reading this article on another website, it was stolen and illegally republished in violation of U.S. and International copyright law. The original version of this story can be read at https://www.americanbankingnews.com/2017/03/20/robert-w-duggan-acquires-205127-shares-of-pulse-biosciences-inc-plse-stock.html

About Pulse Biosciences

Pulse Biosciences, Inc, formerly Electroblate, Inc, is a development-stage medical device company using a platform technology called Nano-Pulse Electro-Signaling (NPES). NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue.

5 Day Chart for NASDAQ:PLSE

Receive News & Ratings for Pulse Biosciences Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pulse Biosciences Inc and related companies with MarketBeat.com's FREE daily email newsletter.